Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine.
about
Insight to drug delivery aspects for colorectal cancerTrial Watch:: Oncolytic viruses for cancer therapyMeasles to the Rescue: A Review of Oncolytic Measles VirusTrial Watch-Oncolytic viruses and cancer therapyViral oncolysis - can insights from measles be transferred to canine distemper virus?Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment.Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer.Gene and cell therapy for pancreatic cancer.CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy.Oncolysis by paramyxoviruses: preclinical and clinical studies.Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo.Fighting Cancer with Mathematics and Viruses.Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination.Potential and clinical translation of oncolytic measles viruses.Oncolytic Immunotherapy for Treatment of Cancer.Viral and Synthetic RNA Vector Technologies and Applications.Advances in the design and development of oncolytic measles viruses.MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus.Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation.Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles.Measles virus: Background and oncolytic virotherapy.Advances in the mechanisms of action of cancer-targeting oncolytic viruses.Advances and Prospects in Cancer Immunotherapy
P2860
Q26774682-7C9290B3-63CB-44B7-A780-D14B0AC63C58Q27021951-6E9AFF46-7A69-40DF-9FC6-3C0589444370Q28072097-D9146824-0C40-4602-A51D-7A16DFDE70B0Q28072347-ADA64139-9967-4EAB-B968-E3263F60984DQ33820717-CEC1E121-667B-4046-9DE5-361613382285Q33899522-6C04EC01-12FD-4FA5-A648-B452E5D9CDA3Q35176800-AC4CFEB6-1796-4EA6-9D92-0FED8037FA2CQ35541787-D0E47AFE-9AA4-4A7C-9763-D49F1B3C4C8DQ35600445-9D87FD6B-C0DB-475A-A5C8-92D9F31C7E03Q35861933-6E4FCEE6-12D4-4599-A32A-1D44110BB309Q37641458-14A04BF1-191E-44A7-8F5E-A17082866A2BQ38612646-E5D699FD-C9A6-40B7-A371-6FFD1857300CQ38752688-62F8D29C-60C7-48F1-9C0F-1856A73F9188Q38764947-C213DF0D-72A9-4724-96A6-B6568FFC814EQ38848223-C19829B4-4B1E-477F-A254-5CEE80EE6182Q38885624-CF4E568A-2F0D-4F3C-A923-D9F4C0952C91Q38924566-952F5292-5E44-409F-8B17-84B60A04A495Q38964020-3F0118D3-9AF8-4552-BA0D-4E9CAD645D5FQ40200208-30C94D0D-DB21-4B13-B323-6205E2556E43Q45323818-D23BB728-0712-4D4A-BD36-1A5190045940Q47554725-BE8992C7-A6AF-4303-99EC-1112425C5BCDQ52655195-F4250D07-F5FC-48F5-BAA7-F6F96312E283Q59072375-7AB1B551-BF56-4843-89C7-AA1CD3364786
P2860
Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Granulocyte-macrophage colony- ...... ve therapeutic cancer vaccine.
@en
Granulocyte-macrophage colony- ...... ve therapeutic cancer vaccine.
@nl
type
label
Granulocyte-macrophage colony- ...... ve therapeutic cancer vaccine.
@en
Granulocyte-macrophage colony- ...... ve therapeutic cancer vaccine.
@nl
prefLabel
Granulocyte-macrophage colony- ...... ve therapeutic cancer vaccine.
@en
Granulocyte-macrophage colony- ...... ve therapeutic cancer vaccine.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Granulocyte-macrophage colony- ...... ve therapeutic cancer vaccine.
@en
P2093
Christian Grossardt
Christoph Springfeld
Dirk Jaeger
Guy Ungerechts
Karim Zaoui
Niels Halama
Sascha Bossow
P2860
P304
P356
10.1089/HUM.2012.205
P577
2013-07-01T00:00:00Z